AI in Medicine News — 2026-11-02 (Mon)

Overview

Diagnosis and imaging saw the most activity, with reports on ultrasound, simulated diagnosis tests and CT analysis, all at research or experimental stages. In drug discovery, large cell datasets were the main theme. On regulation, a Senate draft on Medicare payment for AI performing clinical tasks was the notable item (Medical Daily).

Diagnosis and imaging

- A vision-language AI agent "could help radiologists interpret ultrasounds faster and more accurately." The headline gives no accuracy figures; this is a claim of potential (Medical Xpress). - Microsoft AI beat doctors in a simulated diagnosis test. This is simulated evidence, not clinical use (Fox News). - Penn's experimental AI found hidden disease signals in CT scans, but the headline says it is not ready for patients yet. This is the experimental stage (Medical Daily). - TIME named Israeli medical AI company Aidoc's CARE model among its Best Inventions of 2026. This is a media selection, not a regulatory decision (The Jerusalem Post). - At AHA 2026, AI took center stage, and experts warned it must be built for everyone (MarketScale).

Clinical decision support

- A Nature paper describes a machine learning approach to predicting persistent fever in cancer patients receiving antibiotics. The headline gives no performance figures (Nature). - A former Ogun NMA chair urged the use of AI to improve healthcare, which is an opinion (Punch Newspapers). - "Public Health AI Hubs" was listed as a concept item, with no details in the headline (Trend Hunter). 【Generative AI and medical documentation】 No notable developments. 【Hospital operations and care delivery】 - Palantir is deepening sovereign AI deployments across sensitive industries. The headline does not say which are healthcare (Yahoo Finance). - Tecsys' AI capabilities are aimed at streamlining healthcare supply chains (Supply & Demand Chain Executive). - Nuvilab analyzes nutrients in meals and targets the hospital and senior markets. The headline cites more than 100 million data records (아시아경제, a Korean outlet). - Stakeholders launched an AI initiative to improve mental health screening (The Nation Newspaper). - AI is driving digital transformation in China's primary care (Borneo Post). 【Drug discovery and clinical trials】 No headline states a development stage (preclinical, Phase I, etc.); all items concern tools, datasets or industry trends. - Parse Biosciences and Nomic Bio launched a 100-million-cell immune dataset to advance AI drug discovery (BioPharma APAC). - Cascade, a 100-million-cell AI project, is described as one that "could transform drug discovery" (Kingy AI). - Inductive Bio's Alex Taylor discussed AI in drug discovery (AI Magazine). - AI drug discovery is bringing wet-lab orders, while Chinese CXO Q3 results show a sharp divergence (BigGo Finance). - Exponential View's issue #608 includes 39 charts on Anthropic, a one-person biotech firm and cheap solar. The health-specific content is not clear from the headline (Exponential View | Azeem Azhar). 【Device approvals and regulation】 - A Senate draft could let Medicare test paying for AI that performs clinical tasks without real-time physician review. This is a draft legislative proposal, not an approval, designation or guideline (Medical Daily). - No device approvals or designations appear in the headlines.

Safety, errors and bias

- "The Algorithm Gap: Why AI is Failing Asian Women and What Must Change" raises bias concerns. The headline gives no data (BioSpectrum Asia). - AHA 2026 experts warned AI must be built for everyone (MarketScale). - Penn's CT-analysis AI is not ready for patients yet (Medical Daily). - Nelson Advisors published its weekly European HealthTech, MedTech and Health AI roundup dated October 30, 2026. The headline does not reveal its safety content (https://www.healthcare.digital/). 【Research results (major journals)】 - A Nature paper reports a machine learning approach to predicting persistent fever in cancer patients on antibiotics (Nature). - "Patient AI in Primary Care: 114 Patients, 0 Stops [2026]." The headline does not define the outcome measure (https://tech-insider.org/). - Liam Ghiam asked "What Are the Best Ways to Evaluate Clinical Appropriateness in AI?" (Oncodaily). - MedPage Today covered a pancreatic cancer vaccine and an AI collaboration for managing epilepsy. No efficacy details are given (MedPage Today). - InSight+ ran a piece on how AI can use health data to improve patient care (InSight+).

Developments in Japan

- TV Asahi reported that a dementia drug arrived two years earlier than expected, and asked what lies ahead for AI consultations and cancer treatment (テレ朝NEWS). - A crowdfunding-focused article discusses tackling regional healthcare problems with generative AI and remote image diagnosis (JIJICO). - A market report covers the AI medical diagnosis market, with a focus on overseas opportunities (pando.life). - Two items appear unrelated to medicine: a security-consulting plan for AI-built systems called "健康診断" (Excite) and corporate AI training in Yamaguchi and Hiroshima prefectures (Sanyo Shimbun).

Statements by key figures

No notable developments.